Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19228731 | ENTERAL SUSTAINED-RELEASE SUGAR ALCOHOL ADDITIVE AND PREPARATION METHOD AND APPLICATION THEREOF | June 2025 | November 2025 | Allow | 5 | 1 | 0 | No | No |
| 18632871 | FILAMENTOUS FUNGAL BIOMATS, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE | April 2024 | April 2025 | Allow | 12 | 2 | 0 | No | No |
| 18629983 | METHOD FOR PROPHYLAXIS OF INFECTIONS IN CROPS AND ORNAMENTALS, PREFERABLY IN VITICULTURE, AND IN WOODY PLANTS | April 2024 | October 2025 | Allow | 18 | 1 | 0 | Yes | No |
| 18615574 | FILAMENTOUS FUNGAL BIOMATS, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE | March 2024 | September 2024 | Allow | 6 | 1 | 0 | Yes | No |
| 18603016 | FILAMENTOUS FUNGAL BIOMATS, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE | March 2024 | October 2025 | Abandon | 19 | 0 | 1 | No | No |
| 18511300 | APPLICATION OF BACILLUS COAGULANS IN PREPARING MEDICATION FOR IMPROVING FUNCTIONAL DECLINE OF ORGANISMS CAUSED BY HYPERGLYCEMIA AND HYPERLIPIDEMIA | January 2024 | April 2025 | Abandon | 17 | 1 | 0 | No | No |
| 18419326 | METHOD FOR THE PRODUCTION OF A DAIRY FOOD PRODUCT AND A METHOD FOR GENE TRANSFER BY CONJUGATION | January 2024 | November 2025 | Abandon | 22 | 1 | 0 | No | No |
| 18394616 | RUMINANT COMPOSITIONS | December 2023 | April 2025 | Abandon | 16 | 1 | 0 | No | No |
| 18517905 | Compositions for Fecal Floral Transplantation and Methods for Making and Using Them and Devices for Delivering Them | November 2023 | January 2026 | Abandon | 26 | 1 | 1 | No | No |
| 18381418 | CELLULAR COMPOSITIONS DERIVED FROM PRIOR ORGAN DONORS AND METHODS OF MANUFACTURE AND USE THEREOF | October 2023 | April 2025 | Abandon | 18 | 0 | 1 | No | No |
| 18380292 | METHODS FOR TREATING AND PREVENTING NEUTROPHIL-DERIVED NET TOXICITY AND THROMBOSIS | October 2023 | March 2025 | Abandon | 17 | 0 | 1 | No | No |
| 18281751 | METHOD FOR THE DETECTION OF PARTICLES | September 2023 | March 2026 | Abandon | 30 | 1 | 0 | No | No |
| 18465939 | Composition And Method For Stabilizing And Maintaining The Viability Of Hardy Microorganisms | September 2023 | September 2025 | Abandon | 24 | 0 | 1 | No | No |
| 18464379 | METHOD AND SYSTEMS FOR ISOLATION AND/OR SEPARATION OF PRODUCTS FROM PRODUCTION PROCESSES | September 2023 | May 2025 | Allow | 20 | 3 | 0 | Yes | No |
| 18460124 | BACILLUS COAGULANS FOR IMPROVING CONSTIPATION AND APPLICATION THEREOF | September 2023 | November 2024 | Abandon | 15 | 2 | 0 | No | No |
| 18222943 | METHOD OF INHIBITING MYCOTOXIN GROWTH USING ARTHROSPIRA PLATENSIS NANOPARTICLES | July 2023 | October 2023 | Allow | 3 | 1 | 0 | Yes | No |
| 18210234 | ALGAE-BASED BIOPLASTICS AND METHODS OF MAKING | June 2023 | October 2024 | Allow | 17 | 1 | 0 | Yes | No |
| 18204664 | COMPOSITIONS FOR ESTABLISHING MIXED CHIMERISM AND METHODS OF MANUFACTURE THEREOF | June 2023 | November 2024 | Abandon | 18 | 1 | 0 | No | No |
| 18323328 | METHOD FOR TREATING AND/OR IMPROVING INFLAMMATORY INTESTINAL DISEASE | May 2023 | December 2025 | Allow | 31 | 1 | 0 | No | No |
| 18313312 | TYPE E BOTULINUM TOXIN TO TREAT BOTULISM | May 2023 | March 2024 | Abandon | 10 | 1 | 0 | No | No |
| 18140799 | METHOD OF INHIBITING MYCOTOXIN GROWTH USING ARTHROSPIRA PLATENSIS NANOPARTICLES | April 2023 | October 2023 | Allow | 6 | 1 | 1 | No | No |
| 18246495 | FECAL MATTER FOR PREVENTING OR TREATING INTESTINAL MICROBIOME ABERRATIONS IN CESAREAN SECTION-BORN INFANTS | March 2023 | February 2026 | Allow | 35 | 1 | 0 | No | No |
| 18124346 | CELL CULTURE METHOD FOR MESENCHYMAL STEM CELLS | March 2023 | September 2024 | Allow | 18 | 1 | 0 | Yes | No |
| 18245652 | COMPOSITION FOR IMPROVING DIAGNOSTIC ACCURACY FOR USE IN MAGNIFYING ENDOSCOPY AND ENDOCYTOSCOPY | March 2023 | January 2026 | Abandon | 34 | 1 | 0 | No | No |
| 18179839 | COMPOSITIONS FOR FECAL FLORAL TRANSPLANTATION AND METHODS FOR MAKING AND USING THEM AND DEVICES FOR DELIVERING THEM | March 2023 | September 2023 | Allow | 7 | 1 | 0 | Yes | No |
| 18179801 | COMPOSITIONS FOR FECAL FLORAL TRANSPLANTATION AND METHODS FOR MAKING AND USING THEM AND DEVICES FOR DELIVERING THEM | March 2023 | September 2023 | Allow | 7 | 1 | 0 | Yes | No |
| 18112785 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING DEGENERATIVE MITRAL VALVE DISEASE IN A CANINE | February 2023 | February 2024 | Allow | 12 | 1 | 0 | No | No |
| 18171647 | METHODS FOR A CONTROLLED COENZYME Q10 FERMENTATION PRODUCTION PROCESS | February 2023 | November 2024 | Allow | 21 | 1 | 0 | No | No |
| 18171650 | METHODS FOR A CONTROLLED COENZYME Q10 FERMENTATION PRODUCTION PROCESS | February 2023 | November 2024 | Allow | 21 | 1 | 0 | No | No |
| 18022002 | LABEL-FREE ELECTRICAL MONITORING OF CELL AGGREGATES | February 2023 | January 2026 | Allow | 35 | 1 | 0 | No | No |
| 18168163 | PROBIOTIC BACTERIAL MOLECULES AND THEIR USE IN METHODS TO TREAT/PREVENT INFECTION BY HARMFUL BACTERIA AND TO PROVIDE NUTRITIONAL HEALTH | February 2023 | May 2025 | Abandon | 27 | 2 | 0 | No | No |
| 18004390 | METHOD FOR PREDICTING AND IMPROVING TREATMENT RESPONSE TO INTESTINAL MICROBIOME-BASED CANCER IMMUNOTHERAPY AND METHOD FOR SCREENING FOR CANDIDATE PREBIOTICS | January 2023 | December 2025 | Allow | 35 | 1 | 0 | No | No |
| 18010176 | USE OF BACTERIA IN CHILDREN DEVELOPMENT ASSESSMENT AND TREATMENT | December 2022 | December 2025 | Abandon | 36 | 0 | 1 | No | No |
| 18009969 | Method And System Of Producing A Library Of Microorganisms | December 2022 | January 2026 | Abandon | 38 | 0 | 1 | No | No |
| 18009234 | COMPOSITIONS AND METHODS FOR TREATING LATE-ONSET POMPE DISEASE | December 2022 | September 2025 | Allow | 34 | 1 | 0 | No | No |
| 18007712 | HIGH DOSE AND LOW VOLUME BOTULINUM TOXIN TREATMENT OF FACIAL WRINKLES | December 2022 | October 2025 | Allow | 35 | 1 | 0 | Yes | No |
| 18007713 | COMPOSITIONS AND METHODS FOR TREATING INFECTIONS AND NETOPATHY | December 2022 | November 2025 | Abandon | 35 | 1 | 0 | No | No |
| 18072219 | DIAGNOSTIC TEST | November 2022 | November 2025 | Abandon | 36 | 0 | 1 | No | No |
| 17927052 | COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES, COMPRISING LACTOBACILLUS SAKEI CVL-001 STRAIN | November 2022 | November 2025 | Allow | 35 | 2 | 0 | No | No |
| 17926979 | A PLATFORM FOR SCREENING NAD+ BINDING PROTEINS IN A CELLULAR CONTEXT | November 2022 | June 2025 | Allow | 30 | 0 | 0 | No | No |
| 18056107 | REFERENCE DATASET-BASED, SPECTROMETRIC CHARACTERIZATION OF CELL SUBSTRATES USING SUB-LIBRARIES | November 2022 | October 2025 | Allow | 35 | 1 | 0 | No | No |
| 17937853 | FILAMENTOUS FUNGAL BIOMATS, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE | October 2022 | January 2024 | Allow | 16 | 2 | 0 | Yes | No |
| 17916775 | AEROSOLIZED HYALURONIDASE AND/OR 4-METHYLUMBELLIFERONE COMPOSITIONS AND METHODS OF USING SAME TO TREAT RESPIRATORY DISEASES OR DISORDERS | October 2022 | October 2025 | Abandon | 37 | 1 | 0 | No | No |
| 17942812 | METHOD OF CULTIVATING ALGAE AND PHOTOBIOREACTOR | September 2022 | September 2024 | Allow | 25 | 1 | 0 | No | No |
| 17899561 | METHODS AND COMPOSITIONS RELATED TO COMBINED TREATMENT WITH ANTI-INFLAMMATORIES AND SYNTHETIC NANOCARRIERS COMPRISING AN IMMUNOSUPPRESSANT | August 2022 | September 2024 | Abandon | 25 | 1 | 0 | No | No |
| 17798666 | METHODS AND COMPOSITIONS FOR COMMUNITY-BASED SCREENING OF POLYMICROBIAL INFECTIONS | August 2022 | December 2025 | Abandon | 40 | 1 | 0 | No | No |
| 17797866 | MODIFIED TREATMENT CHAMBER FOR TREATING CELLS | August 2022 | August 2025 | Allow | 37 | 1 | 0 | Yes | No |
| 17876314 | FILAMENTOUS FUNGAL BIOMATS, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE | July 2022 | March 2023 | Allow | 7 | 2 | 0 | No | No |
| 17869863 | METHODS AND COMPOSITIONS RELATED TO COMBINED TREATMENT WITH ANTI-INFLAMMATORIES AND SYNTHETIC NANOCARRIERS COMPRISING AN IMMUNOSUPPRESSANT | July 2022 | September 2024 | Allow | 25 | 1 | 0 | Yes | No |
| 17870093 | COMBINATION THERAPY USING CLOSTRIDIAL TOXIN DERIVATIVE AND AT LEAST ONE CHEMICAL DEPOLARIZING AGENT | July 2022 | November 2024 | Abandon | 28 | 0 | 1 | No | No |
| 17793142 | The Kinase NEK10 and Its Use in Treating and Diagnosing Bronchiectasis and Other Respiratory Disorders | July 2022 | November 2025 | Allow | 40 | 2 | 0 | No | No |
| 17622687 | BIOINTERFACES FOR GROWING SEAWEED | July 2022 | November 2025 | Abandon | 47 | 1 | 0 | No | No |
| 17790272 | COMPOSITIONS COMPRISING A LIPOLYTIC ENZYME VARIANT AND METHODS OF USE THEREOF | June 2022 | October 2025 | Abandon | 40 | 0 | 1 | No | No |
| 17836440 | METHODS FOR TREATING COSTIMULATION BLOCKADE RESISTANT REJECTION | June 2022 | July 2024 | Abandon | 26 | 2 | 0 | No | No |
| 17834252 | Isolated Bacterial Strain of the Genus Burkholderia and Pesticidal Metabolites Therefrom | June 2022 | April 2024 | Allow | 23 | 1 | 0 | Yes | No |
| 17825132 | EXTRACORPOREAL TREATMENT FOR AGING | May 2022 | February 2025 | Abandon | 33 | 0 | 1 | No | No |
| 17778609 | NEW USE OF LACTOBACILLUS PARACASEI SUBSP. PARACASEI K56 IN ALLEVIATION OF INTESTINAL INFLAMMATION | May 2022 | August 2025 | Allow | 39 | 2 | 0 | No | No |
| 17777142 | MASS SPECTROMETRY DETERMINATION OF THE SENSITIVITY OR RESISTANCE OF BACTERIA TO AN ANTIBIOTIC | May 2022 | July 2025 | Allow | 38 | 1 | 0 | No | No |
| 17743097 | DOSING REGIMENS FOR THE MOBILIZATION OF HEMATOPOIETIC STEM CELLS | May 2022 | April 2024 | Abandon | 23 | 1 | 0 | No | No |
| 17742753 | METHODS OF TREATING CELIAC DISEASE | May 2022 | March 2024 | Abandon | 22 | 1 | 0 | No | No |
| 17774974 | METHODS OF TREATING HYPEROXALURIA | May 2022 | September 2025 | Abandon | 41 | 1 | 0 | No | No |
| 17735466 | COMPOSITION AND METHODS FOR PROCESSING A SPUTUM SAMPLE | May 2022 | February 2024 | Allow | 22 | 1 | 0 | Yes | No |
| 17735743 | COMPOSITIONS FOR FECAL FLORAL TRANSPLANTATION AND METHODS FOR MAKING AND USING THEM AND DEVICES FOR DELIVERING THEM | May 2022 | November 2022 | Allow | 7 | 1 | 0 | No | No |
| 17728399 | Methods for Preparation of a Terminally Sterilized Hydrogel Derived from Extracellular Matrix | April 2022 | February 2024 | Allow | 21 | 1 | 0 | No | No |
| 17727465 | MICROBIOME MARKERS AND USES THEREOF | April 2022 | March 2024 | Allow | 22 | 1 | 0 | Yes | No |
| 17720240 | Amelioration and Treatment of Opioid Addiction | April 2022 | April 2025 | Abandon | 36 | 1 | 0 | No | No |
| 17762348 | SEMINAPHTHOFLUOROPHORE-SELENIUM PROBES FOR THIOREDOXIN REDUCTASE | March 2022 | March 2025 | Allow | 36 | 0 | 0 | Yes | No |
| 17760740 | RAPID CELL CULTURE TEST DEVICE DESIGNED SUCH THAT FLUID FILMS WITH UNIFORM THICKNESS ARE FORMED | March 2022 | January 2025 | Allow | 34 | 1 | 0 | No | No |
| 17681529 | Compositions for Fecal Floral Transplantation and Methods for Making and Using Them and Devices for Delivering Them | February 2022 | July 2022 | Allow | 4 | 1 | 0 | Yes | No |
| 17635161 | CHIMERIC VESICULOVIRUSES AND METHODS OF USE | February 2022 | February 2025 | Allow | 36 | 1 | 0 | No | No |
| 17589162 | THERAPEUTIC AGENT FOR DISC HERNIATION | January 2022 | November 2023 | Allow | 22 | 1 | 0 | No | No |
| 17620338 | METHOD FOR CONTROLLING SPEED OF POLYPEPTIDE PASSING THROUGH NANOPORE AND USE THEREOF | December 2021 | July 2025 | Allow | 43 | 1 | 0 | No | No |
| 17547941 | MULTI-LAYER COLLAGEN-BASED MEMBRANE | December 2021 | July 2025 | Allow | 43 | 1 | 1 | No | No |
| 17545911 | FERMENT FROM STRUCTURED WATER MEDIUM AND COSMETIC COMPOSITION COMPRISING THE SAME | December 2021 | March 2025 | Allow | 39 | 3 | 1 | Yes | No |
| 17539186 | FILAMENTOUS FUNGAL BIOMATS, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE | November 2021 | July 2022 | Allow | 8 | 2 | 1 | Yes | No |
| 17615241 | DEVICES, COMPOSITIONS AND METHODS FOR COLONIC MICROBIOME ENGRAFTMENT | November 2021 | March 2025 | Abandon | 40 | 0 | 1 | No | No |
| 17524154 | MICROBES AND METHODS FOR PRODUCING THE SAME | November 2021 | September 2024 | Abandon | 34 | 1 | 0 | No | No |
| 17513186 | APPARATUS AND METHOD WITH ELECTRICAL STIMULUS | October 2021 | August 2025 | Allow | 45 | 1 | 1 | Yes | No |
| 17499014 | Use of Burkholderia Formulations, Compositions and Compounds to Modulate Crop Yield and/or Corn Rootworm Infestation | October 2021 | October 2023 | Allow | 24 | 1 | 0 | No | No |
| 17498391 | METHOD FOR DETERMINING WHETHER OR NOT TEST SAMPLE CONTAINS PHYTOPATHOGENIC FUNGUS | October 2021 | October 2023 | Allow | 24 | 1 | 0 | No | No |
| 17496398 | Compositions for Fecal Floral Transplantation and Methods for Making and Using Them and Devices for Delivering Them | October 2021 | May 2022 | Allow | 7 | 1 | 0 | Yes | No |
| 17489454 | METHOD FOR THE GENERATION OF COMPACT TALE-NUCLEASES AND USES THEREOF | September 2021 | June 2025 | Abandon | 45 | 1 | 0 | No | No |
| 16606158 | COMPOSITIONS COMPRISING PROPIONIBACTERIUM ACNES BACTERIOPHAGES FOR TREATING ACNE | September 2021 | September 2024 | Abandon | 59 | 1 | 0 | No | No |
| 17479230 | Compositions for Fecal Floral Transplantation and Methods for Making and Using Them and Device for Delivering Them | September 2021 | July 2024 | Allow | 34 | 2 | 0 | No | No |
| 17440566 | NOVEL LACTIC ACID BACTERIA STRAINS THAT PROMOTE THE ABSORPTION OF CALCIUM - PEPTIDES AND ASSOCIATED PRODUCTS | September 2021 | February 2025 | Abandon | 41 | 0 | 1 | No | No |
| 17434577 | FOOD MATERIALS COMPRISING FILAMENTOUS FUNGAL PARTICLES AND MEMBRANE BIOREACTOR DESIGN | August 2021 | March 2025 | Allow | 42 | 1 | 0 | No | No |
| 17412177 | PHOSPHATE-SOLUBILIZING MICROBIAL AGENT FOR MAIZE, AND PREPARATION METHOD AND USE THEREOF | August 2021 | March 2025 | Abandon | 43 | 2 | 1 | Yes | No |
| 17409181 | NOVEL BACTERIA AND USES THEREOF | August 2021 | March 2024 | Allow | 31 | 1 | 0 | Yes | No |
| 17406136 | EFFLUENT SAMPLES FROM THE LARGE INTESTINE, INCLUDING THE ACENDING PART, AND RELATED DIAGNOSIS AND TREATMENT | August 2021 | September 2025 | Abandon | 49 | 0 | 1 | No | No |
| 17429237 | COMBINATION THERAPY USING CLOSTRIDIAL TOXIN DERIVATIVE AND AT LEAST ONE CHEMICAL DEPOLARIZING AGENT | August 2021 | November 2024 | Abandon | 39 | 0 | 1 | No | No |
| 17393000 | Compositions and Methods for Reducing Weight Gain | August 2021 | March 2026 | Abandon | 55 | 3 | 1 | No | No |
| 17425079 | NOVEL KAZACHSTANIA TURICENSIS CAU Y1706 AND COMPOSITION USING SAME | July 2021 | August 2024 | Allow | 37 | 2 | 0 | No | No |
| 17378468 | METHOD FOR DETERMINING WHETHER OR NOT TEST SAMPLE CONTAINS PHYTOPATHOGENIC FUNGUS | July 2021 | July 2023 | Allow | 24 | 1 | 0 | No | No |
| 17422868 | Bile Acids and Use in Disease Treatment | July 2021 | January 2024 | Allow | 30 | 1 | 0 | Yes | No |
| 17369012 | MULTIPLEXED SPECTRAL LIFETIME DETECTION OF PHOSPHORS | July 2021 | September 2023 | Abandon | 26 | 0 | 1 | No | No |
| 17368282 | FEED ADDITIVE COMPOSITION | July 2021 | October 2023 | Allow | 28 | 1 | 0 | No | No |
| 17419480 | Methods of Producing Ustekinumab | June 2021 | January 2025 | Allow | 43 | 1 | 0 | No | No |
| 17354967 | THREE-DIMENSIONAL PRINTED ORGANS, DEVICES, AND MATRICES | June 2021 | October 2023 | Allow | 28 | 1 | 0 | Yes | No |
| 17351548 | METHOD FOR THE PRODUCTION OF A DAIRY FOOD PRODUCT AND A METHOD FOR GENE TRANSFER BY CONJUGATION | June 2021 | October 2023 | Allow | 28 | 1 | 0 | No | No |
| 17349366 | METHOD FOR REDUCING BLOOD URIC ACID CONCENTRATION AND FOR DEGRADING PURINE | June 2021 | June 2023 | Allow | 24 | 1 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner PAGUIO FRISING, MICHELLE F.
With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 16.7% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner PAGUIO FRISING, MICHELLE F works in Art Unit 1651 and has examined 545 patent applications in our dataset. With an allowance rate of 68.1%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 29 months.
Examiner PAGUIO FRISING, MICHELLE F's allowance rate of 68.1% places them in the 30% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by PAGUIO FRISING, MICHELLE F receive 1.64 office actions before reaching final disposition. This places the examiner in the 32% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.
The median time to disposition (half-life) for applications examined by PAGUIO FRISING, MICHELLE F is 29 months. This places the examiner in the 62% percentile for prosecution speed. Prosecution timelines are slightly faster than average with this examiner.
Conducting an examiner interview provides a +47.7% benefit to allowance rate for applications examined by PAGUIO FRISING, MICHELLE F. This interview benefit is in the 92% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 32.6% of applications are subsequently allowed. This success rate is in the 69% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.
This examiner enters after-final amendments leading to allowance in 54.9% of cases where such amendments are filed. This entry rate is in the 81% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.
When applicants request a pre-appeal conference (PAC) with this examiner, 160.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 90% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 69.2% of appeals filed. This is in the 55% percentile among all examiners. Of these withdrawals, 100.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 61.2% are granted (fully or in part). This grant rate is in the 65% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 2% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 1.6% of allowed cases (in the 66% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.